Skip to content

Cerebroprotein Hydrolysate

Also called CPH, cerebroprotein hydrolysate injection, 'Cerebrolysin' (mislabelled by some vendors)

A porcine brain-derived peptide preparation.

  • TypeBioregulator
  • FormInjectable
  • Researched forCognitive & Mood

Where to get Cerebroprotein Hydrolysate

Flawless Compounds
Injectable
Code CAMERON

21+ to enter. The only form sold. Research compound, not approved for human use.

Shop injectable at Flawless Compounds

The short version

  • Why people research itCognitive impairment, stroke recovery and traumatic brain injury — the same territory as Cerebrolysin, but it is not the same product.
  • What the evidence isRandomized trials exist, largely from China and India, in acute stroke, traumatic brain injury and vascular cognitive impairment, generally reporting modest improvement on cognitive scales against standard care.
  • What to watchA first seizure.

How Cerebroprotein Hydrolysate works

A porcine brain-derived peptide preparation: brain tissue is enzymatically digested and filtered to leave low-molecular-weight peptides and free amino acids. The proposed action is neurotrophic — the peptide fraction is claimed to mimic the effect of endogenous neurotrophic factors such as BDNF, GDNF and NGF, which are themselves far too large to cross the blood-brain barrier. Small peptides that survive digestion are the proposed messengers.

Read this product's own literature and it defines itself in the words you would use to define Cerebrolysin. Cerebroprotein Hydrolysate-I is ‘a neuropeptide preparation which consists of several amino acids and small molecular peptides’ Wu 2021, and ‘a mixture of hydrolyzed peptides and amino acids’ Zhang 2024.

So the direct answer, because a page that dodged it would be worth less than no page. Cerebrolysin and cerebroprotein hydrolysate are the same class of preparation under two names, and the phrase ‘cerebroprotein hydrolysate’ functions in this literature as the generic description of that class rather than as a trade name. What has not been shown is that they are the same product.

  • Injectable

On the goal map: BDNF & neurotrophic signaling (Focus, memory & cognition)

Research on Cerebroprotein Hydrolysate5 evidence notes: clinical, correlative, mechanism

Each note is labeled by the kind of evidence it stands on. Unproven is not ineffective: a missing trial means nobody has run it yet. How the evidence tiers work

Evidence on file: Chinese and Indian clinical studies in stroke and cognitive impairment; not the same trial base as Cerebrolysin.

Human clinical evidence

  • Randomized trials exist, largely from China and India, in acute stroke, traumatic brain injury and vascular cognitive impairment, generally reporting modest improvement on cognitive scales against standard care. This is a separate evidence base from Cerebrolysin's — different manufacturers, different preparations, and the two are routinely conflated in marketing because the products are cousins.

  • Quality is mixed: many trials are small, single-center, open-label, and published in journals that Western reviewers do not commonly index. That is a reason for caution about effect size, not proof of absence.

Correlative data

  • Used clinically in several Asian markets as an IM or slow-IV course, typically 10-20 days. Practitioner reports center on cognition and recovery after neurological insult rather than on enhancement in healthy people, which is the population most research buyers belong to and the one nobody has studied.

How the mechanism reads

  • Porcine brain tissue is enzymatically digested and filtered to leave low-molecular-weight peptides and free amino acids. The proposal is that these fragments act as neurotrophic mimetics — standing in for BDNF, GDNF and NGF, which are far too large to cross the blood-brain barrier.

    Mechanistic
  • The format is how you tell it apart from Cerebrolysin. That product is this one. A protocol written for one cannot be converted to the other, because the peptide profiles are not the same and neither is standardized against the other.

    Mechanistic

Sources

Cerebroprotein Hydrolysate safety basicsWho should avoid it, what to expect, what to watch

Avoid if

  • A vial whose contents you cannot identify, since this name covers several different products.
  • Epilepsy, as brain-derived peptides can lower the seizure threshold.
  • Pork allergy, because the source is porcine brain tissue.
  • Severe kidney disease.
  • Pregnancy or a young person, where neurotrophic animal extracts are unstudied.

What’s expected

  • Neurotrophic claims rest on cell and rodent work plus a few small trials.
  • Flushing, nausea or dizziness after administration.
  • Effects described as hit-and-run, meaning short exposure with lasting signal.

Watch for

  • A first seizure.
  • Fever, hives or breathing difficulty after use.
  • Confusion or marked sleepiness.

Labs that tell you it’s working

  • Comprehensive Metabolic Panel: renal and liver function for a peptide mixture.
  • Complete Blood Count: raised eosinophils show an immune reaction to animal protein.
  • hs-CRP: a lasting rise suggests the product is provoking inflammation.

Enzymatic digest of porcine brain giving low-molecular-weight peptides and amino acids with proposed neurotrophic action; product identity varies. PMID 34262280 PMID 40964073

Bloodwork to runHow you would know it is working: 9 tests in one order, code CAMERON

Cerebroprotein Hydrolysate FAQ4 common questions

Is Cerebroprotein Hydrolysate approved for human use?
No. Cerebroprotein Hydrolysate is a research compound.
What is Cerebroprotein Hydrolysate researched for?
Cognitive impairment, stroke recovery and traumatic brain injury — the same territory as Cerebrolysin, but it is not the same product.
Which labs show whether it's doing anything?
Comprehensive Metabolic Panel; Complete Blood Count; hs-CRP: a baseline before you start and a recheck after. The panel on this page orders them in one cart.
Where's the full protocol?
In the Skool lesson for Cerebroprotein Hydrolysate: the protocol, dose and schedule, timing, what to stack, the cycle answer, the bloodwork plan and the cheat sheet. Protocol & dosing live there, not on the public site.
The Before-You-Stack Lab Kit cover

The free Before‑You‑Stack Lab Kit

The 12 labs I’d run before any protocol, what each one tells you, add-ons by goal and how to order them yourself. The PDF is yours straight away.

After that it is about two emails a week: a marker, a compound or a protocol. Unsubscribe in one click.

Protocol & dosing: inside Skool

This page covers what Cerebroprotein Hydrolysate is. Skool covers how it is run.

Free on this page

What Cerebroprotein Hydrolysate is and how it works · The research, labeled by the kind of evidence · Its own safety lines and the bloodwork panel

  • What Cerebroprotein Hydrolysate is and how it works
  • The research, labeled by the kind of evidence
  • Its own safety lines and the bloodwork panel

Members get

  • The reported research range, and how each number was reached
  • The protocols: what to run together, in what order, for how long and when to stop
  • The members' prep tool, and live Q&A with Cam every Tuesday
Join Skool $10/mo1,500+ members, 5.0 rating from 15 reviews. Cancel anytime.
The members' Prep Bench in Skool: the compound finder (no dose shown)
The members’ Prep Bench

Want it built around you?

The coaching app, with sample data

1-on-1 coaching with Cam

Your plan, your bloodwork and your check-ins, built around you.

Research Protocol $150/mo · Full Coaching $250/mo

See coaching

One question? Book a 15-minute consult

A call with Cam on the one thing you are stuck on.

$75 per call

Book a consult

Educational and research purposes only. Not medical advice. Research compounds are discussed for research use only, not human use. Some links are affiliate links; Cam may earn a commission at no extra cost to you. Medical disclaimer & affiliate disclosure

Buy with codeJoin Skool